138 related articles for article (PubMed ID: 33212117)
1. Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer.
Perrone F; Craparo EF; Cemazar M; Kamensek U; Drago SE; Dapas B; Scaggiante B; Zanconati F; Bonazza D; Grassi M; Truong N; Pozzato G; Farra R; Cavallaro G; Grassi G
J Control Release; 2021 Feb; 330():1132-1151. PubMed ID: 33212117
[TBL] [Abstract][Full Text] [Related]
2. Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells.
Cavallaro G; Farra R; Craparo EF; Sardo C; Porsio B; Giammona G; Perrone F; Grassi M; Pozzato G; Grassi G; Dapas B
Int J Pharm; 2017 Jun; 525(2):397-406. PubMed ID: 28119125
[TBL] [Abstract][Full Text] [Related]
3. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma.
Huang KW; Lai YT; Chern GJ; Huang SF; Tsai CL; Sung YC; Chiang CC; Hwang PB; Ho TL; Huang RL; Shiue TY; Chen Y; Wang SK
Biomacromolecules; 2018 Jun; 19(6):2330-2339. PubMed ID: 29808997
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs.
Farra R; Scaggiante B; Guerra C; Pozzato G; Grassi M; Zanconati F; Perrone F; Ferrari C; Trotta F; Grassi G; Dapas B
Int J Pharm; 2017 Jun; 525(2):367-376. PubMed ID: 28229942
[TBL] [Abstract][Full Text] [Related]
5. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
6. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery.
Cavallaro G; Licciardi M; Amato G; Sardo C; Giammona G; Farra R; Dapas B; Grassi M; Grassi G
Int J Pharm; 2014 May; 466(1-2):246-57. PubMed ID: 24631053
[TBL] [Abstract][Full Text] [Related]
8. Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma.
Oh HR; Jo HY; Park JS; Kim DE; Cho JY; Kim PH; Kim KS
Nanomaterials (Basel); 2016 Jul; 6(8):. PubMed ID: 28335269
[TBL] [Abstract][Full Text] [Related]
9. Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin: improved antitumor activity against hepatocellular carcinoma with reduced hepatotoxicity.
Cheng X; Gao F; Xiang J; Jiang X; Chen J; Zhang J
Anticancer Drugs; 2011 Feb; 22(2):136-47. PubMed ID: 20966743
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.
Wang G; Gao X; Gu G; Shao Z; Li M; Wang P; Yang J; Cai X; Li Y
Int J Nanomedicine; 2017; 12():3591-3603. PubMed ID: 28533682
[TBL] [Abstract][Full Text] [Related]
12. Strategies to optimize siRNA delivery to hepatocellular carcinoma cells.
Scarabel L; Perrone F; Garziera M; Farra R; Grassi M; Musiani F; Russo Spena C; Salis B; De Stefano L; Toffoli G; Rizzolio F; Tonon F; Abrami M; Chiarappa G; Pozzato G; Forte G; Grassi G; Dapas B
Expert Opin Drug Deliv; 2017 Jun; 14(6):797-810. PubMed ID: 28266887
[TBL] [Abstract][Full Text] [Related]
13. Cationic polyaspartamide-based nanocomplexes mediate siRNA entry and down-regulation of the pro-inflammatory mediator high mobility group box 1 in airway epithelial cells.
Di Gioia S; Sardo C; Belgiovine G; Triolo D; d'Apolito M; Castellani S; Carbone A; Giardino I; Giammona G; Cavallaro G; Conese M
Int J Pharm; 2015 Aug; 491(1-2):359-66. PubMed ID: 26140987
[TBL] [Abstract][Full Text] [Related]
14. Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
Guo Y; Wang J; Zhang L; Shen S; Guo R; Yang Y; Chen W; Wang Y; Chen G; Shuai X
Hepatology; 2016 Apr; 63(4):1240-55. PubMed ID: 26680504
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA-mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma.
Hajiasgharzadeh K; Somi MH; Shanehbandi D; Mokhtarzadeh A; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3263-3276. PubMed ID: 30362510
[TBL] [Abstract][Full Text] [Related]
16. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
[TBL] [Abstract][Full Text] [Related]
17. Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis.
Zhang X; Chen Y; Li X; Xu H; Yang J; Wang C; Zhang C; Deng Y; Lu A; Zheng C; Lu J
Eur J Med Chem; 2024 Mar; 267():116183. PubMed ID: 38354520
[TBL] [Abstract][Full Text] [Related]
18. A novel multifunctional gold nanorod-mediated and tumor-targeted gene silencing of GPC-3 synergizes photothermal therapy for liver cancer.
Liu Y; Tan M; Fang C; Chen X; Liu H; Feng Y; Zhang Y; Min W
Nanotechnology; 2021 Apr; 32(17):175101. PubMed ID: 33445163
[TBL] [Abstract][Full Text] [Related]
19. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
Park MY; Park YS; Nam JH
Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
[TBL] [Abstract][Full Text] [Related]
20. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
